Loading…
Lobbying Spend
—
Filings
16
Firms Hired
1
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend title 38, United States Code, to expand the authority of the Secretary of Veterans Affairs to make grants to entities that furnish services to homeless veterans.
2026 · third_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform; Medicare Diabetes quality measures; Medicare coverage of diabetes - related devices/technology, drugs, and care.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3014
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform; Medicare Diabetes quality measures; Medicare coverage of diabetes - related devices/technology, drugs, and care.
Client expense: — · Firm income: $20,000
Matched citations: S. 4037
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform; Medicare Diabetes quality measures; Medicare coverage of diabetes - related devices/technology, drugs, and care.
Client expense: — · Firm income: $20,000
Matched citations: S. 4189
To amend title 38, United States Code, to expand the authority of the Secretary of Veterans Affairs to make grants to entities that furnish services to homeless veterans.
2026 · second_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3014
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform.
Client expense: — · Firm income: $20,000
Matched citations: S. 4037
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform.
Client expense: — · Firm income: $20,000
Matched citations: S. 4189
Special Diabetes Program Reauthorization Act of 2023
2025 · fourth_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; The Special Diabetes Program Reauthorization Act (H.R. 2550); FDA guidance on diabetes endpoints; Policy related to the use of Continuous Glucose Monitors; The Centers for Medicare and Medicaid Services (CMS) competitive bidding proposal.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2025 · third_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; The Special Diabetes Program Reauthorization Act (H.R. 2550); FDA guidance on diabetes endpoints; Policy related to the use of Continuous Glucose Monitors; The Centers for Medicare and Medicaid Services (CMS) competitive bidding proposal.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2025 · second_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; The Special Diabetes Program Reauthorization Act (H.R. 2550); FDA guidance on diabetes endpoints; Policy related to the use of Continuous Glucose Monitors
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2025 · first_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; The Special Diabetes Program Reauthorization Act (H.R. 2550); FDA guidance on diabetes endpoints; Policy related to the use of Continuous Glucose Monitors
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2024 · fourth_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity The Special Diabetes Program Reauthorization Act (H.R. 2550) Continuing resolution for SDP reauthorization FDA guidance on diabetes endpoints Policy related to the use of Continuous Glucose Monitors
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2024 · third_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity The Special Diabetes Program Reauthorization Act (H.R. 2550) Continuing resolution for SDP reauthorization FDA guidance on diabetes endpoints
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2024 · second_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity The Special Diabetes Program Reauthorization Act (H.R. 2550) Continuing resolution for SDP reauthorization FDA guidance on diabetes endpoints
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2024 · first_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes The Special Diabetes Program Reauthorization Act (H.R. 2550) Continuing resolution for SDP reauthorization FDA guidance on diabetes endpoints
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2023 · fourth_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes; The Special Diabetes Program Reauthorization Act (H.R. 2550); Continuing resolution for SDP reauthorization; FDA guidance on diabetes endpoints
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2023 · third_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes; The Special Diabetes Program Reauthorization Act (H.R. 2550); Continuing resolution for SDP reauthorization
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Special Diabetes Program Reauthorization Act of 2023
2023 · second_quarter · Firm: VENABLE LLP
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes; The Special Diabetes Program Reauthorization Act (H.R. 2550)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2550
Source: Senate LDA